The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
Tóm tắt
Từ khóa
Tài liệu tham khảo
Randle PJ: Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev. 1998, 14: 263-283. 10.1002/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C.
Storlien L, Oakes ND, Kelley DE: Metabolic flexibility. Proc Nutr Soc. 2004, 63: 363-368. 10.1079/PNS2004349.
Galgani JE, Moro C, Ravussin E: Metabolic flexibility and insulin resistance. Am J Physiol Endocrinol Metab. 2008, 295: E1009-E1017. 10.1152/ajpendo.90558.2008.
Sugden MC, Zariwala MG, Holness MJ: PPARs and the orchestration of metabolic fuel selection. Pharmacol Res. 2009, 60: 141-150. 10.1016/j.phrs.2009.03.014.
Gudi R, Bowker-Kinley MM, Kedishvili NY, Zhao Y, Popov KM: Diversity of the pyruvate dehydrogenase kinase gene family in humans. J Biol Chem. 1995, 270: 28989-28994. 10.1074/jbc.270.48.28989.
Sugden MC, Holness MJ: Mechanisms underlying regulation of the expression and activities of the mammalian pyruvate dehydrogenase kinases. Arch Physiol Biochem. 2006, 112: 139-149. 10.1080/13813450600935263.
Strumilo S: Short-term regulation of the mammalian pyruvate dehydrogenase complex. Acta Biochim Pol. 2005, 52: 759-764.
Huang B, Wu P, Popov KM, Harris RA: Starvation and diabetes reduce the amount of pyruvate dehydrogenase phosphatase in rat heart and kidney. Diabetes. 2003, 52: 1371-1376. 10.2337/diabetes.52.6.1371.
Sugden MC, Holness MJ: Interactive regulation of the pyruvate dehydrogenase complex and the carnitine palmitoyltransferase system. FASEB J. 1994, 8: 54-61.
Holness MJ, Sugden MC: Regulation of pyruvate dehydrogenase complex activity by reversible phosphorylation. Biochem Soc Trans. 2003, 31: 1143-1151. 10.1042/BST0311143.
de Lange P, Moreno M, Silvestri E, Lombardi A, Goglia F, Lanni A: Fuel economy in food-deprived skeletal muscle: signaling pathways and regulatory mechanisms. FASEB J. 2007, 21: 3431-3441. 10.1096/fj.07-8527rev.
Kelley DE, Mandarino LJ: Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes. 2000, 49: 677-683. 10.2337/diabetes.49.5.677.
Foster DW: Malonyl-CoA: the regulator of fatty acid synthesis and oxidation. J Clin Invest. 2012, 122: 1958-1959. 10.1172/JCI63967.
Sugden MC, Kraus A, Harris RA, Holness MJ: Fibre-type specific modification of the activity and regulation of skeletal muscle pyruvate dehydrogenase kinase (PDK) by prolonged starvation and refeeding is associated with targeted regulation of PDK isoenzyme 4 expression. Biochem J. 2000, 346 (Pt 3): 651-657.
Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, Harris RA: Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes. 1999, 48: 1593-1599. 10.2337/diabetes.48.8.1593.
Jeoung NH, Wu P, Joshi MA, Jaskiewicz J, Bock CB, Depaoli-Roach AA, Harris RA: Role of pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) in glucose homoeostasis during starvation. Biochem J. 2006, 397: 417-425. 10.1042/BJ20060125.
Furuyama T, Kitayama K, Yamashita H, Mori N: Forkhead transcription factor FOXO1 (FKHR)-dependent induction of PDK4 gene expression in skeletal muscle during energy deprivation. Biochem J. 2003, 375: 365-371. 10.1042/BJ20030022.
Nahle Z, Hsieh M, Pietka T, Coburn CT, Grimaldi PA, Zhang MQ, Das D, Abumrad NA: CD36-dependent regulation of muscle FoxO1 and PDK4 in the PPAR delta/beta-mediated adaptation to metabolic stress. J Biol Chem. 2008, 283: 14317-14326. 10.1074/jbc.M706478200.
Gross DN, van den Heuvel AP, Birnbaum MJ: The role of FoxO in the regulation of metabolism. Oncogene. 2008, 27: 2320-2336. 10.1038/onc.2008.25.
Kase ET, Wensaas AJ, Aas V, Hojlund K, Levin K, Thoresen GH, Beck-Nielsen H, Rustan AC, Gaster M: Skeletal muscle lipid accumulation in type 2 diabetes may involve the liver X receptor pathway. Diabetes. 2005, 54: 1108-1115. 10.2337/diabetes.54.4.1108.
Caton PW, Holness MJ, Bishop-Bailey D, Sugden MC: PPARalpha-LXR as a novel metabolostatic signalling axis in skeletal muscle that acts to optimize substrate selection in response to nutrient status. Biochem J. 2011, 437: 521-530. 10.1042/BJ20110702.
Holness MJ, Kraus A, Harris RA, Sugden MC: Targeted upregulation of pyruvate dehydrogenase kinase (PDK)-4 in slow-twitch skeletal muscle underlies the stable modification of the regulatory characteristics of PDK induced by high-fat feeding. Diabetes. 2000, 49: 775-781. 10.2337/diabetes.49.5.775.
Jeoung NH, Harris RA: Pyruvate dehydrogenase kinase-4 deficiency lowers blood glucose and improves glucose tolerance in diet-induced obese mice. Am J Physiol Endocrinol Metab. 2008, 295: E46-E54. 10.1152/ajpendo.00536.2007.
Hwang B, Jeoung NH, Harris RA: Pyruvate dehydrogenase kinase isoenzyme 4 (PDHK4) deficiency attenuates the long-term negative effects of a high-saturated fat diet. Biochem J. 2009, 423: 243-252. 10.1042/BJ20090390.
Rinnankoki-Tuikka R, Silvennoinen M, Torvinen S, Hulmi JJ, Lehti M, Kivela R, Reunanen H, Kainulainen H: Effects of high-fat diet and physical activity on pyruvate dehydrogenase kinase-4 in mouse skeletal muscle. Nutr Metab (Lond). 2012, 9: 53-10.1186/1743-7075-9-53.
Wende AR, Huss JM, Schaeffer PJ, Giguere V, Kelly DP: PGC-1alpha coactivates PDK4 gene expression via the orphan nuclear receptor ERRalpha: a mechanism for transcriptional control of muscle glucose metabolism. Mol Cell Biol. 2005, 25: 10684-10694. 10.1128/MCB.25.24.10684-10694.2005.
Connaughton S, Chowdhury F, Attia RR, Song S, Zhang Y, Elam MB, Cook GA, Park EA: Regulation of pyruvate dehydrogenase kinase isoform 4 (PDK4) gene expression by glucocorticoids and insulin. Mol Cell Endocrinol. 2010, 315: 159-167. 10.1016/j.mce.2009.08.011.
Araki M, Motojima K: Identification of ERRalpha as a specific partner of PGC-1alpha for the activation of PDK4 gene expression in muscle. FEBS J. 2006, 273: 1669-1680. 10.1111/j.1742-4658.2006.05183.x.
Herbst EA, Dunford EC, Harris RA, Vandenboom R, Leblanc PJ, Roy BD, Jeoung NH, Peters SJ: Role of pyruvate dehydrogenase kinase 4 in regulating PDH activation during acute muscle contraction. Appl Physiol Nutr Metab. 2012, 37: 48-52. 10.1139/h11-136.
Pilegaard H, Neufer PD: Transcriptional regulation of pyruvate dehydrogenase kinase 4 in skeletal muscle during and after exercise. Proc Nutr Soc. 2004, 63: 221-226. 10.1079/PNS2004345.
Constantin-Teodosiu D, Constantin D, Stephens F, Laithwaite D, Greenhaff PL: The role of FOXO and PPAR transcription factors in diet-mediated inhibition of PDC activation and carbohydrate oxidation during exercise in humans and the role of pharmacological activation of PDC in overriding these changes. Diabetes. 2012, 61: 1017-1024. 10.2337/db11-0799.
Eivers SS, McGivney BA, Gu J, MacHugh DE, Katz LM, Hill EW: PGC-1alpha encoded by the PPARGC1A gene regulates oxidative energy metabolism in equine skeletal muscle during exercise. Anim Genet. 2012, 43: 153-162. 10.1111/j.1365-2052.2011.02238.x.
Catoire M, Mensink M, Boekschoten MV, Hangelbroek R, Muller M, Schrauwen P, Kersten S: Pronounced effects of acute endurance exercise on gene expression in resting and exercising human skeletal muscle. PLoS One. 2012, 7: e51066-10.1371/journal.pone.0051066.
Kim YI, Lee FN, Choi WS, Lee S, Youn JH: Insulin regulation of skeletal muscle PDK4 mRNA expression is impaired in acute insulin-resistant states. Diabetes. 2006, 55: 2311-2317. 10.2337/db05-1606.
Nellemann B, Vendelbo MH, Nielsen TS, Bak AM, Hogild M, Pedersen SB, Bienso RS, Pilegaard H, Moller N, Jessen N, Jorgensen JO: Growth hormone-induced insulin resistance in human subjects involves reduced pyruvate dehydrogenase activity. Acta Physiol (Oxf). 2014, 210: 392-402. 10.1111/apha.12183.
Kulkarni SS, Salehzadeh F, Fritz T, Zierath JR, Krook A, Osler ME: Mitochondrial regulators of fatty acid metabolism reflect metabolic dysfunction in type 2 diabetes mellitus. Metabolism. 2012, 61: 175-185. 10.1016/j.metabol.2011.06.014.
Barres R, Osler ME, Yan J, Rune A, Fritz T, Caidahl K, Krook A, Zierath JR: Non-CpG methylation of the PGC-1alpha promoter through DNMT3B controls mitochondrial density. Cell Metab. 2009, 10: 189-198. 10.1016/j.cmet.2009.07.011.
Brons C, Jacobsen S, Nilsson E, Ronn T, Jensen CB, Storgaard H, Poulsen P, Groop L, Ling C, Astrup A, Vaag A: Deoxyribonucleic acid methylation and gene expression of PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-weight-dependent manner. J Clin Endocrinol Metab. 2010, 95: 3048-3056. 10.1210/jc.2009-2413.
Stacpoole PW, Henderson GN, Yan Z, James MO: Clinical pharmacology and toxicology of dichloroacetate. Environ Health Perspect. 1998, 106 (Suppl 4): 989-994. 10.1289/ehp.98106s4989.
Roche TE, Hiromasa Y: Pyruvate dehydrogenase kinase regulatory mechanisms and inhibition in treating diabetes, heart ischemia, and cancer. Cell Mol Life Sci. 2007, 64: 830-849. 10.1007/s00018-007-6380-z.
Morrell JA, Orme J, Butlin RJ, Roche TE, Mayers RM, Kilgour E: AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2. Biochem Soc Trans. 2003, 31: 1168-1170. 10.1042/BST0311168.
Kim YD, Kim YH, Tadi S, Yu JH, Yim YH, Jeoung NH, Shong M, Hennighausen L, Harris RA, Lee IK: Metformin inhibits growth hormone-mediated hepatic PDK4 gene expression through induction of orphan nuclear receptor small heterodimer partner. Diabetes. 2012, 61: 2484-2494. 10.2337/db11-1665.
Jeoung NH, Harris RA: Role of pyruvate dehydrogenase kinase 4 in regulation of blood glucose levels. Korean Diabetes J. 2010, 34: 274-283. 10.4093/kdj.2010.34.5.274.
Hwang B, Wu P, Harris RA: Additive effects of clofibric acid and pyruvate dehydrogenase kinase isoenzyme 4 (PDK4) deficiency on hepatic steatosis in mice fed a high saturated fat diet. FEBS J. 2012, 279: 1883-1893. 10.1111/j.1742-4658.2012.08569.x.
Tao R, Xiong X, Harris RA, White MF, Dong XC: Genetic inactivation of pyruvate dehydrogenase kinases improves hepatic insulin resistance induced diabetes. PLoS One. 2013, 8: e71997-10.1371/journal.pone.0071997.
Sugden MC, Fryer LG, Priestman DA, Orfali KA, Holness MJ: Increased hepatic pyruvate dehydrogenase kinase activity in fed hyperthyroid rats: studies in vivo and with cultured hepatocytes. Mol Cell Endocrinol. 1996, 119: 219-224. 10.1016/0303-7207(96)03817-8.
Holness MJ, Bulmer K, Smith ND, Sugden MC: Investigation of potential mechanisms regulating protein expression of hepatic pyruvate dehydrogenase kinase isoforms 2 and 4 by fatty acids and thyroid hormone. Biochem J. 2003, 369: 687-695. 10.1042/BJ20021509.
Sugden MC, Lall HS, Harris RA, Holness MJ: Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. J Endocrinol. 2000, 167: 339-345. 10.1677/joe.0.1670339.
Sugden MC, Langdown ML, Harris RA, Holness MJ: Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J. 2000, 352 (Pt 3): 731-738.
Attia RR, Connnaughton S, Boone LR, Wang F, Elam MB, Ness GC, Cook GA, Park EA: Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by thyroid hormone: role of the peroxisome proliferator-activated receptor gamma coactivator (PGC-1 alpha). J Biol Chem. 2010, 285: 2375-2385. 10.1074/jbc.M109.039081.
Attia RR, Sharma P, Janssen RC, Friedman JE, Deng X, Lee JS, Elam MB, Cook GA, Park EA: Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta). J Biol Chem. 2011, 286: 23799-23807. 10.1074/jbc.M111.246389.
Nye CK, Hanson RW, Kalhan SC: Glyceroneogenesis is the dominant pathway for triglyceride glycerol synthesis in vivo in the rat. J Biol Chem. 2008, 283: 27565-27574. 10.1074/jbc.M804393200.
Holness MJ, Zariwala G, Walker CG, Sugden MC: Adipocyte pyruvate dehydrogenase kinase 4 expression is associated with augmented PPARgamma upregulation in early-life programming of later obesity. FEBS Open Bio. 2012, 2: 32-36.
Cadoudal T, Distel E, Durant S, Fouque F, Blouin JM, Collinet M, Bortoli S, Forest C, Benelli C: Pyruvate dehydrogenase kinase 4: regulation by thiazolidinediones and implication in glyceroneogenesis in adipose tissue. Diabetes. 2008, 57: 2272-2279. 10.2337/db08-0477.
Sears DD, Hsiao A, Ofrecio JM, Chapman J, He W, Olefsky JM: Selective modulation of promoter recruitment and transcriptional activity of PPARgamma. Biochem Biophys Res Commun. 2007, 364: 515-521. 10.1016/j.bbrc.2007.10.057.
Wan Z, Thrush AB, Legare M, Frier BC, Sutherland LN, Williams DB, Wright DC: Epinephrine-mediated regulation of PDK4 mRNA in rat adipose tissue. Am J Physiol Cell Physiol. 2010, 299: C1162-C1170. 10.1152/ajpcell.00188.2010.
Wan Z, Frier BC, Williams DB, Wright DC: Epinephrine induces PDK4 mRNA expression in adipose tissue from obese, insulin resistant rats. Obesity (Silver Spring). 2012, 20: 453-456. 10.1038/oby.2011.252.
Jeong JY, Jeoung NH, Park KG, Lee IK: Transcriptional regulation of pyruvate dehydrogenase kinase. Diabetes Metab J. 2012, 36: 328-335. 10.4093/dmj.2012.36.5.328.
Zhao G, Jeoung NH, Burgess SC, Rosaaen-Stowe KA, Inagaki T, Latif S, Shelton JM, McAnally J, Bassel-Duby R, Harris RA: Overexpression of pyruvate dehydrogenase kinase 4 in heart perturbs metabolism and exacerbates calcineurin-induced cardiomyopathy. Am J Physiol Heart Circ Physiol. 2008, 294: H936-H943. 10.1152/ajpheart.00870.2007.
Zhang L, Mori J, Wagg C, Lopaschuk GD: Activating cardiac E2F1 induces up-regulation of pyruvate dehydrogenase kinase 4 in mice on a short term of high fat feeding. FEBS Lett. 2012, 586: 996-1003. 10.1016/j.febslet.2012.02.027.
Mori J, Alrob OA, Wagg CS, Harris RA, Lopaschuk GD, Oudit GY: ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. Am J Physiol Heart Circ Physiol. 2013, 304: H1103-H1113. 10.1152/ajpheart.00636.2012.
Jha MK, Jeon S, Suk K: Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders. Curr Neuropharmacol. 2012, 10: 393-403. 10.2174/157015912804499528.
Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD: Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2009, 106: 14670-14675. 10.1073/pnas.0903563106.
Nakai N, Obayashi M, Nagasaki M, Sato Y, Fujitsuka N, Yoshimura A, Miyazaki Y, Sugiyama S, Shimomura Y: The abundance of mRNAs for pyruvate dehydrogenase kinase isoenzymes in brain regions of young and aged rats. Life Sci. 2000, 68: 497-503. 10.1016/S0024-3205(00)00947-4.
Michelakis ED, Sutendra G, Dromparis P, Webster L, Haromy A, Niven E, Maguire C, Gammer TL, Mackey JR, Fulton D: Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med. 2010, 2: 31ra34-
Poplawski MM, Mastaitis JW, Yang XJ, Mobbs CV: Hypothalamic responses to fasting indicate metabolic reprogramming away from glycolysis toward lipid oxidation. Endocrinology. 2010, 151: 5206-5217. 10.1210/en.2010-0702.
Ding F, Li HH, Li J, Myers RM, Francke U: Neonatal maternal deprivation response and developmental changes in gene expression revealed by hypothalamic gene expression profiling in mice. PLoS One. 2010, 5: e9402-10.1371/journal.pone.0009402.
Xu J, Han J, Epstein PN, Liu YQ: Regulation of PDK mRNA by high fatty acid and glucose in pancreatic islets. Biochem Biophys Res Commun. 2006, 344: 827-833. 10.1016/j.bbrc.2006.03.211.
Wallace M, Whelan H, Brennan L: Metabolomic analysis of pancreatic beta cells following exposure to high glucose. Biochim Biophys Acta. 1830, 2013: 2583-2590.
Akhmedov D, De Marchi U, Wollheim CB, Wiederkehr A: Pyruvate dehydrogenase E1alpha phosphorylation is induced by glucose but does not control metabolism-secretion coupling in INS-1E clonal beta-cells. Biochim Biophys Acta. 1823, 2012: 1815-1824.
Arumugam R, Horowitz E, Noland RC, Lu D, Fleenor D, Freemark M: Regulation of islet beta-cell pyruvate metabolism: interactions of prolactin, glucose, and dexamethasone. Endocrinology. 2010, 151: 3074-3083. 10.1210/en.2010-0049.
Hsu PP, Sabatini DM: Cancer cell metabolism: Warburg and beyond. Cell. 2008, 134: 703-707. 10.1016/j.cell.2008.08.021.
Wu CA, Chao Y, Shiah SG, Lin WW: Nutrient deprivation induces the Warburg effect through ROS/AMPK-dependent activation of pyruvate dehydrogenase kinase. Biochim Biophys Acta. 2013, 1833: 1147-1156. 10.1016/j.bbamcr.2013.01.025.
Houten SM, Chegary M, Te Brinke H, Wijnen WJ, Glatz JF, Luiken JJ, Wijburg FA, Wanders RJ: Pyruvate dehydrogenase kinase 4 expression is synergistically induced by AMP-activated protein kinase and fatty acids. Cell Mol Life Sci. 2009, 66: 1283-1294. 10.1007/s00018-009-9066-x.